Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 12-08-2015 | Practice Area: | Corporate and M&A |
| Deal Title: | Janssen Biotech - Alligator Bioscience Directed Immunotherapy License | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Alligator Bioscience AB, a privately held Swedish biotech company developing immune-oncology antibodies for directed immunotherapy of cancer, entered into a definitive agreement with Janssen Biotech, Inc. (Janssen). Under the agreement, Janssen, was granted an exclusive, worldwide license to Alligator Bioscience AB's clinical candidate ADC-1013 that currently is in Phase I clinical trials.
Setterwalls team was led by Ola Grahn.
|
||
| Financial Center: | Stockholm | Value: | 0.00-0.00 |
| Advised Party: | Service Recipient | Law Firm | Setterwalls |
| Contract Counterparty | Sweden | Contract Counterparty | United States |
| Classification: |
Commercial Contracts and Outsourcing Licensing |
Lawyer | Ola Grahn |
